Company Filing History:
Years Active: 2019-2024
Title: Innovations by David Alcorta in Cancer Therapy
Introduction
David Alcorta is an accomplished inventor based in Durham, NC, known for his significant contributions to cancer treatment technologies. With a total of four patents to his name, Alcorta has focused on developing innovative methods and systems that enhance the efficacy of cancer therapies.
Latest Patents
Among his latest patents is the X-ray psoralen activated cancer therapy (X-PACT), which presents a method for treating diseased sites in human or animal bodies. This method involves injecting phosphors capable of emitting ultraviolet or visible light into the affected area. Additionally, he has developed a system for the same therapy, which includes a pharmaceutical carrier with phosphors, a photoactivatable drug for DNA intercalation, devices for drug infusion, an x-ray or high-energy electron source, and a processor to control the dosage of x-rays or electrons. This innovative approach aims to activate the photoactivatable drug within tumors, enhancing treatment effectiveness.
Career Highlights
David Alcorta has worked with notable organizations such as Immunolight, LLC and Duke University. His work in these institutions has allowed him to advance his research and contribute to the field of cancer therapy significantly.
Collaborations
Alcorta has collaborated with esteemed colleagues, including Frederic Avery Bourke, Jr. and Neil Lee Spector, further enriching his research and development efforts in cancer treatment technologies.
Conclusion
David Alcorta's innovative work in cancer therapy, particularly through his X-PACT patents, showcases his commitment to improving treatment methods. His contributions are paving the way for more effective cancer therapies, ultimately benefiting patients in need.